Pure Global

Evaluating FEijoa foR DIabetes Prevention in a Multi-ethnic New ZeAlaND Cohort: the FERDINAND study. A community nutrition intervention in individuals with pre-diabetes. - Trial ANZCTR12622000210774

Access comprehensive clinical trial information for ANZCTR12622000210774 through Pure Global AI's free database. This Not Applicable trial is sponsored by The university of Auckland and is currently Recruiting. The study focuses on Prediabetes.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ANZCTR12622000210774
Not Applicable
Recruiting
other
Trial Details
Australian New Zealand Clinical Trials Registry โ€ข ANZCTR12622000210774
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Evaluating FEijoa foR DIabetes Prevention in a Multi-ethnic New ZeAlaND Cohort: the FERDINAND study. A community nutrition intervention in individuals with pre-diabetes.

Study Focus

Prediabetes

Interventional

other

Sponsor & Location

The university of Auckland

New Zealand National Science Challenge High Value Nutrition Programme, New Zealand Ministry of Business, Innovation and Enterprise (MBIE)

New Zealand

Timeline & Enrollment

Not Applicable

Sep 13, 2022

N/A

Primary Outcome

Measure change in fasting plasma glucose ;; Change in body weight (using digital scales)

Summary

Prevention of type 2 diabetes (T2D) is a key global health target, with change in diet being a first line strategy. Yet the optimum composition of the diet for long term prevention, to enhance outcomes that can be achieved through weight loss, remains under considerable debate. Additionally, response to dietary intervention, in particular the postprandial glucose response (PPGR), remains poorly characterised in those at risk of diabetes. Predicting response, and in turn personalising intervention diets to optimise glycaemic improvements in high risk individuals is an important step in understanding how diet may help to ameliorate dysglycaemia and T2D.. The proposed FERDINAND Study is a longer-term 8 month intervention in a larger multi-ethnic cohort of โ€˜at riskโ€™ adults; with the aim of evaluating a F&B product that may contribute to improved glycaemia during both weight/adipose mass loss and longer-term weight loss maintenance. Plant-derived polyphenols, commonly found in fruits such as feijoa, may provide a novel nutrition approach with evidence from prior pre-clinical, and a human clinical study, demonstrating improvement in glycaemic parameters following short-term consumption of commercially available whole feijoa powder. Use of machine-learning algorithms will integrate clinical responses and โ€˜omics outputs to predict individual response to the intervention. The outcomes of PPGR from the FERDINAND Cohort will be important as it will provide predictive algorithms that can be validated in future follow-up assessments.

ICD-10 Classifications

Diabetes mellitus
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, unspecified
Other specified diabetes mellitus
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

Data Source

Australian New Zealand Clinical Trials Registry

ANZCTR12622000210774

Non-Device Trial